Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex
about
Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1)Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.The human microbiome is a source of therapeutic drug targets.Mechanisms of apoptosis induction by nucleoside analogs.Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signalingRepair of topoisomerase I-mediated DNA damage.Structural studies of type I topoisomerases.Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalphaEnhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.Topoisomerase inhibitors as anticancer agents: a patent update.Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.Effect of cytosine arabinoside on cerebellar neurofilaments during development: A sexual dimorphism.Rad9 protects cells from topoisomerase poison-induced cell death.Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.DNA cleavage assay for the identification of topoisomerase I inhibitors.Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine
P2860
Q24299565-E3A1054A-6960-4071-8046-D21AEB09CF85Q30837074-54701049-1814-408D-BD6B-BC2C0BFB6AF0Q34726528-D65160ED-FC05-45AF-9CB6-78BE732EFA05Q35603389-BD01AC62-F4FF-49BB-92C3-BAD13F610F65Q35692042-0B62DA77-0583-4C68-8CDF-76E418CEEAD7Q36557533-3B76D678-DFEC-46A1-B68E-CC9565427186Q37108394-C2AC6BF6-4F7A-4A9C-84B5-8A81D9682B5BQ37323539-0CBBA39E-41DD-4A54-A1BE-7E714A0F0152Q37592361-B51BCCDE-0F87-4365-865E-42E164CAE0F1Q38101143-F4A41764-C8D7-40E6-804E-BAF49772920EQ40308617-15CF2BD5-1F23-47ED-9C24-F5E211B116C6Q41681170-BD9E0BCC-1DD6-400F-8A84-5E8AD7A1A321Q44779418-8F4CE1EF-CA90-4759-8445-162DFA7BA69DQ45096277-5EA18E1C-1D10-4FEB-8FAC-FB03B9CE9600Q45110862-69EE4395-66F9-413B-B445-DE8410788947Q46312378-3D6DACB0-1085-4B22-AC7F-E1FFDD64548BQ58714285-1673D0DE-711B-4896-AC1D-A47394286318
P2860
Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@ast
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@en
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@nl
type
label
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@ast
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@en
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@nl
prefLabel
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@ast
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@en
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@nl
P2093
P2860
P356
P1476
Structural impact of the leuke ...... an topoisomerase I-DNA complex
@en
P2093
Alex B Burgin
Jill E Chrencik
Lance Stewart
P2860
P304
P356
10.1074/JBC.M212930200
P407
P577
2003-04-04T00:00:00Z